SERO-OBS Corona: Serological Studies for SARS-CoV-2 in Germany

An observatory of seroepidemiological studies for SARS-CoV-2 in Germany, compiled by the Robert Koch Institute. The project systematically identifies studies from registries, literature databases, and media reports since spring 2020. Results are made available and regularly updated on dedicated German and English websites.

Use Cases

• Estimate the frequency of SARS-CoV-2 infections in different population groups based on antibody test results.
• Calculate the underreporting factor for COVID-19 cases by comparing serological prevalence to reported case numbers.
• Track the temporal evolution of population immunity through studies conducted at different points during the pandemic.

Strengths

• Compiles multiple independent serological studies from Germany, providing a consolidated view.
• Data is systematically identified from registries, literature databases, and media, suggesting a structured methodology.
• Results are published and regularly updated on official Robert Koch Institute websites.

Limitations

• Row count and specific column definitions are unknown, limiting suitability assessment.
• The last update date is unknown; freshness is unverified.
• Column-level documentation is absent; field semantics must be inferred after download.

Provenance

Source

Robert Koch Institute

Collection Method

Systematic searches in study registries, literature databases including preprints, and media reports.

Time Range

Studies conducted since spring 2020.

Geography

Germany